Renal Stone DiseaseNCT07864194
Direct In-Scope Suction Versus Standard Flexible Ureterorenoscopy
A study testing Standard flexible ureterorenoscope and Flexible ureterorenoscope with direct in-scope suction in people with Renal Stone Disease, run by Hitit University at 1 site in Turkey (Türkiye).
Trial summary
This prospective study aims to compare the clinical, perioperative, and postoperative outcomes of flexible ureterorenoscopy using a direct in-scope suction system (DISS) with standard flexible ureterorenoscopy in patients undergoing retrograde intrarenal surgery for renal or proximal ureteral stones. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Renal Stone Disease
- What is being tested?
- Standard flexible ureterorenoscope and Flexible ureterorenoscope with direct in-scope suction
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 7 Jul 2026to 15 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged 18 years or older.
- A single stone located in the kidney or proximal ureter.
- Scheduled to undergo retrograde intrarenal surgery (RIRS) by the study's surgical team.
Who cannot join
- Multiple renal or proximal ureteral stones.
- Age younger than 18 years.
- Pregnancy.
- Preoperative urinary tract infection.
- Bleeding diathesis.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Department of Urology, Hitit University Çorum Erol Olçok Training and Research Hospital, Çorum, Türkiye
Çorum, Çorum, 19040
AHMET TAŞCI, 05531596690, ahmettasci400@gmail.com
AHMET TAŞCI
About this study
Official title: Flexible Ureterorenoscope With Suction: An Innovative Approach
This prospective study aims to compare the clinical, perioperative, and postoperative outcomes of flexible ureterorenoscopy using a direct in-scope suction system (DISS) with standard flexible ureterorenoscopy in patients undergoing retrograde intrarenal surgery for renal or proximal ureteral stones. A total of 70 patients will be enrolled, with 35 patients in each group. The study will assess postoperative infectious complications, including fever, systemic inflammatory response syndrome (SIRS), and sepsis, as well as operative parameters, length of hospital stay, reoperation, and stone-free status. Stone-free status will be assessed by non-contrast computed tomography four weeks after surgery.
Read the detailed description
Retrograde intrarenal surgery (RIRS) is used to treat renal and proximal ureteral stones. During flexible ureterorenoscopy, stone fragments and irrigation fluid may impair visualization, and elevated intrarenal pressure may contribute to postoperative infectious complications. Direct in-scope suction (DISS) permits aspiration through the ureterorenoscope during irrigation and lithotripsy. This study will compare procedural and postoperative outcomes with and without DISS.
This single-center, prospective, randomized, parallel-group study will enroll 70 adults undergoing RIRS at Erol Olçok Training and Research Hospital. Participants will be assigned in a 1:1 ratio to standard flexible ureterorenoscopy or DISS-equipped flexible ureterorenoscopy using a computer-generated randomization sequence. Each group will include 35 participants. Clinical data will be collected during surgery and postoperative follow-up.
The standard group will undergo surgery using a 7.5 Fr Storz Flex-X2 flexible ureterorenoscope. The DISS group will undergo surgery using a 7.5 Fr single-use Claritron flexible ureterorenoscope with direct in-scope suction. Both groups will use a 9.5/11.5 Fr ureteral access sheath, guidewire, Holmium:YAG laser lithotripsy, and normal saline irrigation. Procedures will be performed under general anesthesia in the lithotomy position, with the irrigation bag positioned approximately 100 cm above the patient.
Eligible patients will be aged 18 years or older and undergo RIRS by the same surgical team for a single renal or proximal ureteral stone. Patients with multiple stones, pregnancy, preoperative urinary tract infection, or bleeding diathesis will be excluded.
Demographic and stone characteristics, operative time, fluoroscopy time, total laser energy, length of hospital stay, and need for reoperation will be recorded. Laboratory results, including white blood cell count, C-reactive protein, and creatinine, as well as urine and blood culture results when obtained, will be collected during follow-up.
The primary outcomes are postoperative fever, systemic inflammatory response syndrome (SIRS), and sepsis. Fever is defined as a body temperature >38°C within 48 hours after surgery. SIRS is defined as the presence of at least two of the following: temperature >38°C or <36°C, heart rate >90 beats/min, respiratory rate >20 breaths/min, or white blood cell count >12,000/mm³ or <4,000/mm³. For this protocol, sepsis is defined as SIRS with suspected or confirmed infection. For patients who develop infectious complications, treatment, intravenous antibiotic use, and intensive care requirements will be recorded.
Secondary outcomes include stone-free status on non-contrast computed tomography approximately four weeks after surgery, postoperative changes in white blood cell count and creatinine, and postoperative culture findings. Residual fragments ≤4 mm will be classified as clinically insignificant for the study's stone-free assessment.
The two groups will be compared using tests appropriate for the distribution and type of each variable. Categorical data will be reported as counts and percentages. A p value <0.05 will be considered statistically significant.
- Conditions
- Renal Stone Disease
- Being tested
- Standard flexible ureterorenoscope, Flexible ureterorenoscope with direct in-scope suction
- Keywords
- Retrograde intrarenal surgery (RIRS), Kidney stone, Infectious complications, Urinary tract infection, Sepsis
- Medical subject headings
- Kidney Calculi, Urinary Tract Infections, Sepsis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard flexible ureterorenoscopeDevice
A 7.5 Fr reusable Storz Flex-X2 flexible ureterorenoscope without direct in-scope suction will be used for retrograde intrarenal surgery. Stone fragmentation will be performed with a Holmium:YAG laser through a 9.5/11.5 Fr ureteral access sheath.
Flexible ureterorenoscope with direct in-scope suctionDevice
A 7.5 Fr single-use Claritron flexible ureterorenoscope equipped with direct in-scope suction will be used for retrograde intrarenal surgery. Suction through the scope will be available during irrigation and Holmium:YAG laser lithotripsy. A 9.5/11.5 Fr ureteral access sheath will be used.
| Study group | Role | What they receive |
|---|---|---|
| Standard Flexible Ureterorenoscopy | Active comparator | Participants randomized to this arm will undergo retrograde intrarenal surgery using a 7.5 Fr Storz Flex-X2 flexible ureterorenoscope without direct in-scope suction. A 9.5/11.5 Fr ureteral access sheath, Holmium:YAG laser lithotripsy, and normal saline irrigation will be used. Receives: Device: Standard flexible ureterorenoscope |
| Direct In-Scope Suction Flexible Ureterorenoscopy | Experimental | Participants randomized to this arm will undergo retrograde intrarenal surgery using a 7.5 Fr single-use Claritron flexible ureterorenoscope equipped with direct in-scope suction. A 9.5/11.5 Fr ureteral access sheath, Holmium:YAG laser lithotripsy, and normal saline irrigation will be used. Receives: Device: Flexible ureterorenoscope with direct in-scope suction |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of Postoperative Fever
Number and percentage of participants with a recorded body temperature >38°C within 48 hours after surgery.
Measured: Within 48 hours after surgery
Secondary outcomes (3)
Incidence of Postoperative Systemic Inflammatory Response Syndrome
Number and percentage of participants meeting at least two of the following criteria: temperature >38°C or <36°C, heart rate >90 beats/min, respiratory rate >20 breaths/min, or white blood cell count >12,000/mm³ or <4,000/mm³.
Measured: Within 48 hours after surgery
Incidence of Postoperative Sepsis
Number and percentage of participants with suspected or confirmed infection who also meet the protocol-defined systemic inflammatory response syndrome criteria.
Measured: Within 48 hours after surgery
Stone-Free Rate
Number and percentage of participants with no residual stone or residual fragments ≤4 mm on non-contrast computed tomography.
Measured: 4 weeks after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2026
- Study start7 Jul 2026
- Primary completion30 Oct 2026 (estimated)
- Study completion15 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Renal Stone DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hitit University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mustafa Serdar CAGLAYAN, Hitit University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07864194
- Sponsor's protocol ID
- ETIK-2026-34
- Status last verified
- Sep 2026
- First submitted
- 27 Sep 2026
- Last updated
- 7 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Patel PU, Uy M, Dauw C, Sui W, Plott J, Roberts WW, Ghani KR. Direct in-scope suction (DISS) ureteroscopy: techniques, outcomes and future directions. BJU Int. 2026 Mar;137 Suppl 3(Suppl 3):S19-S28. doi: 10.1111/bju.16871. Epub 2025 Aug 5.
PubMed 40763000
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Flexible Ureterorenoscope With Suction: An Innovative Approach
- ClinicalTrials.gov ID
- NCT07864194
- Acronym / sponsor ID
- ETIK-2026-34
- Conditions
- Renal Stone Disease
- Keywords
- Retrograde intrarenal surgery (RIRS), Kidney stone, Infectious complications, Urinary tract infection, Sepsis
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Hitit UniversityUniversity, hospital or other
- Study start
- 7 Jul 2026 (actual)
- Primary completion
- 30 Oct 2026 (estimated)
- Study completion
- 15 Nov 2026 (estimated)
- First posted
- 7 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective study aims to compare the clinical, perioperative, and postoperative outcomes of flexible ureterorenoscopy using a direct in-scope suction system (DISS) with standard flexible ureterorenoscopy in patients undergoing retrograde intrarenal surgery for renal or proximal ureteral stones. A total of 70 patients will be enrolled, with 35 patients in each group. The study will assess postoperative infectious complications, including fever, systemic inflammatory response syndrome (SIRS), and sepsis, as well as operative parameters, length of hospital stay, reoperation, and stone-free status. Stone-free status will be assessed by non-contrast computed tomography four weeks after surgery.
Detailed description
Retrograde intrarenal surgery (RIRS) is used to treat renal and proximal ureteral stones. During flexible ureterorenoscopy, stone fragments and irrigation fluid may impair visualization, and elevated intrarenal pressure may contribute to postoperative infectious complications. Direct in-scope suction (DISS) permits aspiration through the ureterorenoscope during irrigation and lithotripsy. This study will compare procedural and postoperative outcomes with and without DISS.
This single-center, prospective, randomized, parallel-group study will enroll 70 adults undergoing RIRS at Erol Olçok Training and Research Hospital. Participants will be assigned in a 1:1 ratio to standard flexible ureterorenoscopy or DISS-equipped flexible ureterorenoscopy using a computer-generated randomization sequence. Each group will include 35 participants. Clinical data will be collected during surgery and postoperative follow-up.
The standard group will undergo surgery using a 7.5 Fr Storz Flex-X2 flexible ureterorenoscope. The DISS group will undergo surgery using a 7.5 Fr single-use Claritron flexible ureterorenoscope with direct in-scope suction. Both groups will use a 9.5/11.5 Fr ureteral access sheath, guidewire, Holmium:YAG laser lithotripsy, and normal saline irrigation. Procedures will be performed under general anesthesia in the lithotomy position, with the irrigation bag positioned approximately 100 cm above the patient.
Eligible patients will be aged 18 years or older and undergo RIRS by the same surgical team for a single renal or proximal ureteral stone. Patients with multiple stones, pregnancy, preoperative urinary tract infection, or bleeding diathesis will be excluded.
Demographic and stone characteristics, operative time, fluoroscopy time, total laser energy, length of hospital stay, and need for reoperation will be recorded. Laboratory results, including white blood cell count, C-reactive protein, and creatinine, as well as urine and blood culture results when obtained, will be collected during follow-up.
The primary outcomes are postoperative fever, systemic inflammatory response syndrome (SIRS), and sepsis. Fever is defined as a body temperature >38°C within 48 hours after surgery. SIRS is defined as the presence of at least two of the following: temperature >38°C or <36°C, heart rate >90 beats/min, respiratory rate >20 breaths/min, or white blood cell count >12,000/mm³ or <4,000/mm³. For this protocol, sepsis is defined as SIRS with suspected or confirmed infection. For patients who develop infectious complications, treatment, intravenous antibiotic use, and intensive care requirements will be recorded.
Secondary outcomes include stone-free status on non-contrast computed tomography approximately four weeks after surgery, postoperative changes in white blood cell count and creatinine, and postoperative culture findings. Residual fragments ≤4 mm will be classified as clinically insignificant for the study's stone-free assessment.
The two groups will be compared using tests appropriate for the distribution and type of each variable. Categorical data will be reported as counts and percentages. A p value <0.05 will be considered statistically significant.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Standard Flexible Ureterorenoscopy | Active comparator | Device: Standard flexible ureterorenoscopeParticipants randomized to this arm will undergo retrograde intrarenal surgery using a 7.5 Fr Storz Flex-X2 flexible ureterorenoscope without direct in-scope suction. A 9.5/11.5 Fr ureteral access sheath, Holmium:YAG laser lithotripsy, and normal saline irrigation will be used. |
| Direct In-Scope Suction Flexible Ureterorenoscopy | Experimental | Device: Flexible ureterorenoscope with direct in-scope suctionParticipants randomized to this arm will undergo retrograde intrarenal surgery using a 7.5 Fr single-use Claritron flexible ureterorenoscope equipped with direct in-scope suction. A 9.5/11.5 Fr ureteral access sheath, Holmium:YAG laser lithotripsy, and normal saline irrigation will be used. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Adults aged 18 years or older.
- A single stone located in the kidney or proximal ureter.
- Scheduled to undergo retrograde intrarenal surgery (RIRS) by the study's surgical team.
Key exclusion criteria (5 listed)
- Multiple renal or proximal ureteral stones.
- Age younger than 18 years.
- Pregnancy.
- Preoperative urinary tract infection.
- Bleeding diathesis.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard flexible ureterorenoscopeA 7.5 Fr reusable Storz Flex-X2 flexible ureterorenoscope without direct in-scope suction will be used for retrograde intrarenal surgery. Stone fragmentation will be performed with a Holmium:YAG laser through a 9.5/11.5 Fr ureteral access sheath. | Device | Standard Flexible Ureterorenoscopy |
| Flexible ureterorenoscope with direct in-scope suctionA 7.5 Fr single-use Claritron flexible ureterorenoscope equipped with direct in-scope suction will be used for retrograde intrarenal surgery. Suction through the scope will be available during irrigation and Holmium:YAG laser lithotripsy. A 9.5/11.5 Fr ureteral access sheath will be used. | Device | Direct In-Scope Suction Flexible Ureterorenoscopy |
Primary outcome
Incidence of Postoperative Fever
Time frame: Within 48 hours after surgery
Number and percentage of participants with a recorded body temperature >38°C within 48 hours after surgery.
3 secondary outcomes
Incidence of Postoperative Systemic Inflammatory Response Syndrome
Time frame: Within 48 hours after surgery
Incidence of Postoperative Sepsis
Time frame: Within 48 hours after surgery
Stone-Free Rate
Time frame: 4 weeks after surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2026.
- Background: PubMed 40763000Patel PU, Uy M, Dauw C, Sui W, Plott J, Roberts WW, Ghani KR. Direct in-scope suction (DISS) ureteroscopy: techniques, outcomes and future directions. BJU Int. 2026 Mar;137 Suppl 3(Suppl 3):S19-S28. doi: 10.1111/bju.16871. Epub 2025 Aug 5.
- Individual participant dataSharing planned: No
Related trials for Renal Stone Disease
RecruitingPhase 1/2
Dexamethasone for Ureteral STent Symptoms (DUSTS)
Ureteral Stent-Related Symptom
Not yet recruitingEarly Phase 1
Phosphate & Kidney Stones
Kidney Stones, Calcium Oxalate Kidney Stones
Recruiting
Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology
Urolithiasis, Stones, Kidney
Active, not recruitingObservational study
A Retrospective, Multi-center Real-world Study of Steerable Ureteroscopic Renal Evacuation (SURE) Procedure With the CVAC® System
Urolithiasis, Kidney Stone
Recruiting
Supervised Endoscopic Tele-controlled Intelligent Lithotripsy
Renal Stone
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Standard flexible ureterorenoscope and Flexible ureterorenoscope with direct in-scope suction in people with Renal Stone Disease, run by Hitit University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact MUSTAFA SERDAR ÇAĞLAYAN (+90 507 431 1951, serdar.09.09@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of Postoperative Fever (time frame: Within 48 hours after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07864194, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.